A detailed history of State Of Wyoming transactions in Biolife Solutions Inc stock. As of the latest transaction made, State Of Wyoming holds 1,742 shares of BLFS stock, worth $37,714. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,742
Previous 1,585 9.91%
Holding current value
$37,714
Previous $33,000 30.3%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.19 - $26.52 $3,012 - $4,163
157 Added 9.91%
1,742 $43,000
Q2 2024

Aug 14, 2024

BUY
$15.14 - $22.99 $1,741 - $2,643
115 Added 7.82%
1,585 $33,000
Q1 2024

May 13, 2024

SELL
$15.35 - $18.82 $1,366 - $1,674
-89 Reduced 5.71%
1,470 $27,000
Q4 2023

Feb 14, 2024

SELL
$8.99 - $16.86 $7,443 - $13,960
-828 Reduced 34.69%
1,559 $25,000
Q3 2023

Nov 14, 2023

BUY
$10.81 - $22.96 $8,096 - $17,197
749 Added 45.73%
2,387 $32,000
Q2 2023

Aug 14, 2023

BUY
$17.19 - $24.34 $5,724 - $8,105
333 Added 25.52%
1,638 $36,000
Q1 2023

May 12, 2023

BUY
$17.67 - $26.07 $1,590 - $2,346
90 Added 7.41%
1,305 $28,000
Q4 2022

Feb 14, 2023

SELL
$16.95 - $25.07 $118 - $175
-7 Reduced 0.57%
1,215 $22,000
Q3 2022

Nov 14, 2022

SELL
$14.64 - $26.7 $1,376 - $2,509
-94 Reduced 7.14%
1,222 $28,000
Q2 2022

Aug 15, 2022

SELL
$10.54 - $24.2 $35,298 - $81,045
-3,349 Reduced 71.79%
1,316 $18,000
Q1 2022

May 13, 2022

BUY
$20.81 - $37.29 $28,447 - $50,975
1,367 Added 41.45%
4,665 $106,000
Q4 2021

Feb 11, 2022

BUY
$32.99 - $58.55 $7,191 - $12,763
218 Added 7.08%
3,298 $123,000
Q3 2021

Feb 11, 2022

SELL
$42.03 - $60.5 $22,570 - $32,488
-537 Reduced 14.85%
3,080 $130,000
Q2 2021

Feb 11, 2022

BUY
$29.51 - $44.62 $106,737 - $161,390
3,617 New
3,617 $161,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $924M
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.